Seizure Detection Devices for use in Antiseizure Medication Clinical Trials: A Systematic Review


The need to address key limitations in validation studies is highlighted in order to support future assessments of SDD fitness for ASM clinical trial use. In tandem, a stepwise framework to streamline device testing is put forth. These suggestions provide a starting point for establishing SDD reporting requirements before device integration into ASM clinical trials.


Leave A Reply